A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis

NCT02504294 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
432
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer

Collaborators